首页|Concentric Centrifugal Figurate Erythema as an Unusual COVID-19 Evanescent Skin Manifestation in a Patient With CD3+/CD45+Lymphocyte Infiltration:A Case Report

Concentric Centrifugal Figurate Erythema as an Unusual COVID-19 Evanescent Skin Manifestation in a Patient With CD3+/CD45+Lymphocyte Infiltration:A Case Report

扫码查看
Introduction:Coronavirus disease 2019(COVID-19)may be associated with various skin manifestations.Among them,figurate erythema(FE)is rare;only a few clinical reports have been published.Herein,we reported an unusual concentric FE lesions and their immunohistochemical profile in a patient with COVID-19.Case presentation:A 52-year-old woman was diagnosed with COVID-19.One month later,she developed asymptomatic annular erythematous concentric ring lesions on her inner right thigh.The margin of every ring increased in coloration,and the lesions then completely resolved in 2 weeks.A biopsy revealed vasculitis of small vessels,an increase in the fluorescence intensity of CD3 and CD45,and negativity for COVID-19 RNA.Discussion:The results showed an unusual FE that has a clinical mixed type between erythema annulare centrifugum and erythema gyratum repens;the physiopathological mechanism in the FE due to COVID-19 is unknown;one theory involves rapid viral passage into the cutaneous vascular system that triggers an immune and inflammatory response.Although the results exhibited a negative COVID-19 RNA in the tissue,the CD3+/CD45+lymphocyte infiltration could explain the clinical pattern as a direct inflammatory response in the small vessel or as a delayed immune response.Conclusion:Our findings suggest an immunohistochemical small vessel vasculitis pattern with an unusual clinical FE that differs from other types of COVID-19-associated FE or erythema reported previously.

erythemaCOVID-19leukocytoclastic vasculitisskin manifestationCD3 complexCD45 antigen

Lucía Achell Achell-Nava、José Luis Zaldivar-Fujigaki、Rebeca Pérez-Cabeza de Vaca、Ana Maria Espinosa García、Luis Montiel López

展开 >

Dermatology Department,National Medical Center 20 de Noviembre,ISSSTE,Mexico City 03229,Mexico

Biomedical Research Department,National Medical Center 20 de Noviembre,ISSSTE,Mexico City 03100,Mexico

Clinical Pharmacology Division,General Hospital of Mexico,Mexico City 06720,Mexico

Internal Medicine Department,National Medical Center 20 de Noviembre,ISSSTE,Mexico City 03100,Mexico

展开 >

2024

国际皮肤性病学杂志
中华医学会,中国医学科学院皮肤病研究所

国际皮肤性病学杂志

CSTPCD
影响因子:0.276
ISSN:1673-4173
年,卷(期):2024.7(2)